Yuma Kitase, Nethra K Madurai, Sarah Hamimi, Ryan L Hellinger, O Angel Odukoya, Sindhu Ramachandra, Sankar Muthukumar, Vikram Vasan, Riley Sevensky, Shannon E Kirk, Alexander Gall, Timothy Heck, Maide Ozen, Benjamin C Orsburn, Shenandoah Robinson, Lauren L Jantzie
Introduction: Novel therapeutics are emerging to mitigate damage from perinatal brain injury (PBI). Few newborns with PBI suffer from a singular etiology. Most experience cumulative insults from prenatal inflammation, genetic and epigenetic vulnerability, toxins (opioids, other drug exposures, environmental exposure), hypoxia-ischemia, and postnatal stressors such as sepsis and seizures. Accordingly, tailoring of emerging therapeutic regimens with endogenous repair or neuro-immunomodulatory agents for individuals requires a more precise understanding of ligand, receptor-, and non-receptor-mediated regulation of essential developmental hormones...
2023: Frontiers in Physiology